PTC THERAPEUTICS, INC. - 8-K Filing
PTC Therapeutics agreed to acquire ST-920 gene therapy from Sangamo for $111M upfront plus up to $100M in milestone payments. (Items: 1.01 Entry into a Material Definitive Agreement)
Tickers: $PTCT
More Regulatory news
- Marvell Technology, Inc. - 8-K Filing
- VISHAY INTERTECHNOLOGY INC - 8-K Filing
- CENTRUS ENERGY CORP - 8-K Filing
- SAGA COMMUNICATIONS INC - 8-K Filing
- NextBoat Inc. - 8-K Filing
- CIVISTA BANCSHARES, INC. - 8-K Filing
- RF Acquisition Corp II - 10-Q Filing
- ORASURE TECHNOLOGIES INC - 10-Q Filing
- Rocket Companies, Inc. - 8-K Filing
- Applied Aerospace & Defense, Inc. - 10-Q Filing